This is a non-core endpoint: only basic statistics are computed.
Testicular hypofunction, drug-induced
E4_TESTICHYPO_ADVERSE
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule
189303
Check conditions None
189303
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
7
Check minimum number of events None
7
Include endpoints None
7
Remove individuals based on genotype QC
7
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Testicular hypofunction, drug-induced based on the number of shared cases.
Broader endpoints:
- Testicular hypofunction
- Testicular dysfunction
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any reimbursement code in KELA
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 7 | - | 7 |
Unadjusted prevalence (%) | 0.00 | - | 0.00 |
Mean age at first event (years) | 37.80 | - | 37.80 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_TESTICHYPO_ADVERSE – Testicular hypofunction, drug-induced
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Testicular hypofunction, drug-induced
↥Endpoint not on priority list, no data to show.